On June 27, 2025, the U.S. Supreme Court held, in a 6-3 decision in Trump v. Casa, that federal courts lack the authority to issue nationwide injunctions under the Judiciary Act of 1789 (Judiciary Act). In doing so, the Court...more
At a Glance -
MFN Pricing Returns: The EO revives effort to link U.S. drug prices to those in peer countries, calling for voluntary industry action.
Aggressive Action on the Table: If progress on voluntary price cuts...more
5/22/2025
/ Department of Health and Human Services (HHS) ,
Drug Pricing ,
Executive Orders ,
Federal Trade Commission (FTC) ,
Food and Drug Administration (FDA) ,
Most-Favored Nations ,
Pharmaceutical Industry ,
Popular ,
Proposed Rules ,
Regulatory Reform ,
Trump Administration